DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» PDGFRB
PDGFRB
Platelet-Derived Growth Factor Receptor Expression and Amplification in Choroid Plexus Carcinomas
Pdgfrβ Regulates Adipose Tissue Expansion and Glucose
60+ Genes Tested FDA-Approved Targeted Therapies & Gene Indicators
PSM, a Mediator of PDGF-BB-, IGF-I-, and Insulin-Stimulated Mitogenesis
PDGFRB FISH for Gleevec Eligibility in Myelodysplastic Syndrome/Myeloproliferative Disease (MDS/MPD)
Platelet-Derived Growth Factor Isoform Expression in Carbon Tetrachloride
Abstract: Dissecting PDGFRB Function in NPM- ALK Driven Lymphoma
PDGFRB FISH Patient Information Sheet
PDGFRB Gene Platelet Derived Growth Factor Receptor Beta
Transactivation of Pdgfrb by Dopamine D4 Receptor Does Not
NIH Public Access Author Manuscript Clin Pharmacol Ther
An Activated Receptor Tyrosine Kinase, TEL PDGF R, Cooperates With
Moguntinones—New Selective Inhibitors for the Treatment of Human Colorectal Cancer
Cell Profiling of Mouse Acute Kidney Injury Reveals Conserved Cellular Responses to Injury
510(K) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY
Spotlight on Midostaurin in the Treatment of FLT3-Mutated Acute Myeloid Leukemia and Systemic Mastocytosis: Design, Development, and Potential Place in Therapy
Hereditary Cancer Panel Descriptions
PDGFRB Mutants Found in Patients with Familial Infantile Myofibromatosis Or Overgrowth Syndrome Are Oncogenic and Sensitive to I
Top View
Structural and Functional Characterisation of the Thrombopoietin Receptor
Pdgfrb Expression and Function in Fibroblasts Derived from Pluripotent Cells Is Linked to DNA Demethylation
Distinct Effects of Ligand-Induced Pdgfra and Pdgfrb Signaling in the Human Rhabdomyosarcoma Tumor Cell and Stroma Cell Compartments
Mouse Platelet-Derived Growth Factor Receptor a Gene Is Deleted in WJ9H and Patch Mutations on Chromosome 5 E
Regulation of PDGFR Signaling
Dimerization Drives EGFR Endocytosis Through Two Sets of Compatible
Class Effects of Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
Proteomic Approach Toward Determining the Molecular Background of Pazopanib Resistance in Synovial Sarcoma
Obesity and Diabetes
Immune Cell Guide
Pdgfrα/HER2 and Pdgfrα/P53 Co-Expression in Oral Squamous
Enhancer Remodeling During Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-Tefb Complex
Crosstalk Between PDGF and IGF-I Receptors in Rat Liver Myofibroblasts: Implication for Liver Fibrogenesis
Mechanisms of Receptor Tyrosine Kinase Activation in Cancer Zhenfang Du1 and Christine M
Molecular Analysis of PDGFRA and PDGFRB Genes
The Yin and Yang of Discoidin Domain Receptors (Ddrs): Implications in Tumor Growth and Metastasis Development
Ephrin-B2 Controls Pdgfrb Internalization and Signaling
Endogenous Dendritic Cells from the Tumor Microenvironment Support T-ALL Growth Via IGF1R Activation
De-Repression of Pdgfrb Transcription Promotes Acquired
Prevalence of Germline Mutations in Cancer Susceptibility Genes In
The Pdgfrb–AKT Pathway Contributes to CDDP-Acquired Resistance in Testicular Germ Cell Tumors
Rare Gene Fusion Rearrangement SPTNB1-PDGFRB in an Atypical Myeloproliferative Neoplasm
CD38&Minus; Integrin Α2&Minus
Targeting DDR1 and DDR2 Overcomes Matrix-Mediated Melanoma Cell Adaptation to BRAF-Targeted Therapy
Platelet-Derived Growth Factor Receptor Β Activation and Regulation In
Sorafenib Inhibits Imatinib-Resistant KIT and Platelet-Derived Growth
Profiling Phospho-Signaling Networks in Breast Cancer Using Reverse
Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug
PDGFRB-Associated Chronic Eosinophilic Leukemia
Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective C-Met Kinase Inhibitor
A Patient with Germ-Line Gain-Of-Function PDGFRB P.N666H Mutation and Marked Clinical Response to Imatinib
Transcriptional Activation of the Axl and PDGFR-A by C-Met Through A
PDGFRB Promotes Liver Metastasis Formation of Mesenchymal-Like Colorectal Tumor Cells
Investigating the Influence of Perinatal Nicotine and Alcohol Exposure On
Platelet-Derived Growth Factor Receptors Differentially Inform Intertumoral and Intratumoral Heterogeneity
Kank1/Pdgfrb
The Role of RICTOR Downstream of Receptor Tyrosine Kinase in Cancers Ahlem Jebali1,2 and Nicolas Dumaz1,2*
The Current Genomic and Molecular Landscape of Philadelphia-Like Acute Lymphoblastic Leukemia
Identification of Novel Determinants of Resistance to Lapatinib in ERBB2-Amplified Cancers
Regulation of Neuroblastoma Differentiation by Forkhead Transcription Factors FOXO1/3/4 Through the Receptor Tyrosine Kinase PDGFRA
NDEL1-PDGFRB Fusion Gene in a Myeloid Malignancy with Eosinophilia Associated with Resistance to Tyrosine Kinase Inhibitors
With Flt3 Affinity Molecule Receptor Tyrosine Kinase Inhibitor And
Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma
Source Target LCK ZAP70 EGFR ERBB2 RIPK1 RIPK3 RPS6KA3 MAPK1 SRC EGFR SRC PTK2 SYK LCK SRC ERBB2 SRC PTK2B SRC KDR FYN PRKCD
Expression Profiling of Fibroblasts in Chronic and Acute Disease Models Reveals Novel Pathways in Kidney Fibrosis
Mir-939 Acts As Tumor Suppressor by Modulating JUNB Transcriptional
Negative Chronic Myeloproliferative Neoplasms ⁎ Tariq I
STAT Signaling in Hematological Malignancies
Overview of Genes Derived from Possum Database in the Category and Subcategories of Skin Vascular Changes (N=139)
Role of Platelet-Derived Growth Factors in Physiology and Medicine
Platelet-Derived Growth Factor BB Stimulates Differentiation of Rat Immature Leydig Cells
Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor S
Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
Tyrosine Kinase Receptors in Oncology